" class="no-js "lang="en-US"> NYU Langone Health Archives - Medtech Alert
Tuesday, March 21, 2023

Sort by:


Top Post

Plugging Immune Cell Leakage from Tumors Could Improve Skin Cancer Treatment

The number of specialized immune cells available for fighting skin cancer doubled when a new […]

Fluent BioSciences Launches Industry's Most Accessible, Cost-effective and Scalable Technology (PIPseq™) to Accelerate Adoption of Single-cell RNA Sequencing in Any Laboratory

Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every […]

Largest Clinical Study Validating A Blood-based Colorectal Screening Test Completes Enrollment

Freenome, a privately held biotech company, announced the completion of enrollment for PREEMPT CRC, the […]

Structure of a Bacterial "Drug Pump" Reveals New Way to Counter Hospital-borne Infection

By revealing the structure of a protein used by bacteria to pump out antibiotics, a […]

Researchers Discover New Model for "Global" DNA Repair

Two studies provide a radically new picture of how bacterial cells continually repair damaged sections […]

NYU Langone Health Launches Parekh Center for Interdisciplinary Neurology to Accelerate Scientific Discovery

NYU Langone Health announced today the launch of the Parekh Center for Interdisciplinary Neurology, made possible […]

Artificial Intelligence Tool Improves Accuracy of Breast Cancer Imaging

A computer program trained to see patterns among thousands of breast ultrasound images can aid […]

FDA Clears NYU Langone Genome PACT

The U.S. Food and Drug Administration (FDA) has cleared for clinical lab use a gene […]

New Class of Compounds Found to Block Coronavirus Reproduction

A human genetic mechanism hijacked by SARS-CoV-2, the coronavirus behind the COVID-19 pandemic, to help […]

Cancer-Killing Virus Therapy Shows Promise Against Inoperable Skin Cancers

Early results show that a new combination drug therapy is safe and effective against advanced […]

  1. Axel Hoos, MD, PhD, Joins NextPoint Therapeutics Board of Directors Read more
  2. Coya Therapeutics Announces Positive Results from a Proof-of-Concept Academic Clinical Study for COYA 302 in Amyotrophic Lateral Sclerosis (ALS) Read more
  3. BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint in New Jersey Read more
  4. Mindset Health Raises $12M to Expand Digital Hypnotherapy Apps & Scale Distribution Read more
  5. GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey” Read more